NeuroPace RNS Implant Contract Approved by Parkland
Trusted by teams at
Description
Parkland Health approved a three‑year, $450,000 sole‑source contract with NeuroPace, Inc. for RNS Neurostimulator implant systems to support surgical treatment of drug‑resistant epilepsy. The agreement runs from May 21, 2026 through May 20, 2029 and expands the hospital’s advanced neuromodulation capabilities.
Contract Details
Contract Amount
$450,000
Vendor
NEUROPACE INC
Agency
Parkland Health & Hospital System, TX
Contract Type
SUPPLIES
Document Date
May 18, 2026
Contract Term
5/21/2026 – 5/20/2029
Renewal Date
2029-05-20
Renewal Info
Base term three‑year agreement from 5/21/2026–5/20/2029 for RNS implants; no out‑year renewal options described.
More from NEUROPACE INC
More from Parkland Health & Hospital System
Dallas County Hospital District Budget, Finance & Infrastructure Committee Agenda May 2026
Dallas County Hospital District Budget, Finance & Infrastructure Committee Agenda May 2026
Parkland Health Board of Managers Agenda Packet May 2026
Dallas County Hospital District Budget, Finance & Infrastructure Committee Agenda May 2026
Parkland Health Board of Managers Agenda Packet May 2026
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.